Sign in
Explore the registryTrack Ly3884963's trials

PROCLAIM

Phase 1/2 Clinical Trial of LY3884963 in Patients With Frontotemporal Dementia With Progranulin Mutations (FTD-GRN)

LY3884963OngoingActive not recruitingPhase 1Open NCT04408625 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…